Top Markets
Coin of the day
Alseres Pharmaceuticals, Inc. Alseres Pharmaceuticals, Inc.

Alseres Pharmaceuticals, Inc.

ALSE
Classement en actions #42806
Alseres Pharmaceuticals, Inc. focuses on creating both diagnostic and... Alseres Pharmaceuticals, Inc. focuses on creating both diagnostic and therapeutic solutions, with a primary emphasis on ailments affecting the central nervous system. Their flagship experimental compound is Altropane, a molecular imaging agent developed for identifying and diagnosing Parkinson's disease and dementia. Founded in 1972, the company was previously known as Boston Life Sciences, Inc. before officially changing its name to Alseres Pharmaceuticals, Inc. in June 2007. Its operations are headquartered in Auburndale, Massachusetts.
Prix de l'action
$0.01
Dernière synchronisation: 2024-08-19
Capitalisation boursière
$61.27
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Alseres Pharmaceuticals, Inc. (ALSE)

Catégorie

Ratio P/S pour Alseres Pharmaceuticals, Inc. (ALSE)
Ratio P/S au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Alseres Pharmaceuticals, Inc., le ratio cours/ventes actuel (TTM) est 0. À la fin de 2026, le ratio P/S était de 0.
Historique du ratio P/S pour Alseres Pharmaceuticals, Inc. de 2026 à 2026
Ratio P/S à la fin de chaque année
Année Ratio P/S Changez
Pas assez de données pour les dates fournies.
Ratio P/S pour des entreprises similaires ou concurrentes
Entreprise Ratio P/S Différence de Ratio P/S Pays
9.88 -
US
10.30 -
NL
- -
CH
4.98 -
BE
- -
KR